Framework Journal · one stock, one dated entry

Recorded 2026-07-27 · Permanent

Experian plc logoExperian plc EXPGY

Clears both ethical standards

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

The label
Distribution

read at $37.35

Experian plc holds its Distribution at $37.35.

PHINPOOPSC
  • PHPhase · the trend structure carries the Distribution label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · passes the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2026-07-27
PhaseDistribution · caution
Quantitative stateElevated stress, defensive posture warranted, held for 1 days
Price$37.35
Valuation22.91 trailing · 16.35 forward price to earnings
Values screenPASS
Beta0.83

The opportunity · what the numbers say it is worth

Our framework reads AVOID — it trades at roughly a 19% discount to our $44.34 fair value, strong competitive moat, 12.30% revenue growth.

Read at
$37.35
22.91 P/E · 16.35 fwd
Our fair value
$44.34
19% discount
Analyst target (avg)
$43.00
+15% to current
Target low $42.00Analyst target rangeTarget high $57.00
▲ current $37.35 · | average target

Price history & projections · where it has been, where the models see it going

$58.8$45.8$32.7TODAY5y agoPROJECTIONAnalyst high$57.00 +62%Our fair value$44.34 +26%Analyst avg$43.00 +22%Conservative$37.80 +7%

The valuation journey · where the price sits against fair value and the Street

Current
$37.35
you are here
Conservative
$37.80
+1%
Analyst avg
$43.00
+15%
Our fair value
$44.34
+19%
Analyst high
$57.00
+53%

Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Revenue growth12.30%
Profit margin17.79%
Debt to equity100.32
Analyst consensusStrong Buy · 3 covering

Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.

The values screen, explained · five checks, plain English

This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:

The common standard · AAOIFI
Used by most halal investing apps
✓ PASSES
Our stricter standard · asset-based
The one Titan applies
✓ PASSES

What these two standards are, and how they differ →

  • Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
  • Debt load Interest-bearing debt is just 17.8% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
  • Interest-bearing cash Cash held in interest-bearing accounts and securities is 1.0% of assets, under the one-third limit. Pass
  • Receivables Money owed to the company is 0.0% of assets, under the 49% limit. Pass
  • Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass

Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.

The business, in plain words · what the numbers mean

Credit Data Leader Draws Analyst Love Yet We Pass

Every time a bank runs a mortgage check or a retailer verifies an identity, Experian sits behind the scenes handling the data flow. The business prints 12 percent revenue growth, 18 percent profit margins and 28 percent ROE with a strong moat intact.

Yet we pass. The name carries a strong buy rating from the two analysts who cover it and a 50 dollar median target, but the 16.1 times forward multiple already prices in most of that quality at the current 36.54 dollar share price.

Risk sits with tighter data privacy rules that could lift compliance costs and squeeze the 18 percent margin over time. Ethical screen passes yet the valuation leaves no real margin for error. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E16.4x
priced for continued growth
Trailing P/E22.9x
a premium valuation
Revenue growth12.3%
steady growth
Profit margin17.8%
healthy profit margins
Return on equity28.3%
an exceptional return on shareholder capital
Debt to equity1.00
a meaningful debt load worth watching
Current ratio0.85
below 1 — short-term bills exceed liquid assets
Beta0.83
steadier than the market
Market cap$33.0B

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Latest news · what the market is reading on EXPGY

Headlines from third-party outlets, linked for reference — not our reporting, not advice.

Related securities · others in EXPGY's space worth a look

Screened names in the same industry · explore each on its own page.

Where & how to trade · wherever in the world you are

EXPGY trades on OQX. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The trader read · the latest dated commentary

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (3 analysts) rates it strong buy, with a mean price target of $55. Entered 2026-07-28 · Distribution

The dated journal · newest first, never edited

2026-07-28 Distribution $37.35 +7.3% Entry 4

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.3% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (3 analysts) rates it strong buy, with a mean price target of $55.

2026-07-18 Distribution $34.82 +0.0% Entry 3

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 30%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (3 analysts) rates it strong buy, with a mean price target of $55.

2026-07-03 Distribution $34.82 +0.0% Entry 2

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Distribution $34.82 Entry 1

The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $36.24 -2.9% · $971 -2.9%
2 months $34.51 +1.9% · $1,019 +1.9%
3 months $37.36 -5.8% · $942 -5.8%
6 months $43.84 -19.8% · $803 -19.8%
1 year $50.13 -29.8% $0.43 $710 -29.0%
2 years $45.45 -22.6% $1.03 $797 -20.3%
3 years $34.74 +1.3% $1.59 $1,058 +5.8%
5 years $35.68 -1.4% $2.60 $1,059 +5.9%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever EXPGY does next, these words stay.

Experian plc · EXPGY · Distribution · $37.35
Recorded 2026-07-27 · before the outcome · scored mechanically

Get our weekly market brief free.